TP53 and prostate cancer: In conclusion, the findings in the present study suggest that A. salmonea suppresses cell cycle progression and induces apoptosis, thereby inhibiting the viability of androgen-sensitive prostate cancer cells through activating p53 and inhibiting androgen receptor signaling in the nucleus (Figure 6).